{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:56:24Z","timestamp":1769072184730,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2017,10,5]]},"DOI":"10.1038\/hr.2017.56","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T06:03:49Z","timestamp":1493273029000},"page":"892-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension"],"prefix":"10.1038","volume":"40","author":[{"given":"Shigemasa","family":"Tani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Asayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Oiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Harasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kushiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"BFhr201756_CR1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903\u20131913.","journal-title":"Lancet"},{"key":"BFhr201756_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","volume":"21","author":"CM Lawes","year":"2003","unstructured":"Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S . Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707\u2013716.","journal-title":"J Hypertens"},{"key":"BFhr201756_CR3","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"The SPRINT Research Group","year":"2015","unstructured":"The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103\u20132116.","journal-title":"N Engl J Med"},{"key":"BFhr201756_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","volume":"57","author":"SD Persell","year":"2011","unstructured":"Persell SD . Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57: 1076\u20131080.","journal-title":"Hypertension"},{"key":"BFhr201756_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.jhh.1002320","volume":"22","author":"T Obara","year":"2008","unstructured":"Obara T, Ohkubo T, Asayama K, Metoki H, Inoue R, Kikuya M, Kato T, Tanaka K, Hara A, Hashimoto J, Totsune K, Imai Y . Home blood pressure measurements associated with better blood pressure control: the J-HOME study. J Hum Hypertens 2008; 22: 197\u2013204.","journal-title":"J Hum Hypertens"},{"key":"BFhr201756_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ . Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122: 290\u2013300.","journal-title":"Am J Med"},{"key":"BFhr201756_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/hr.2015.64","volume":"38","author":"M Hosaka","year":"2015","unstructured":"Hosaka M, Metoki H, Satoh M, Ohkubo T, Asayama K, Kikuya M, Inoue R, Obara T, Hirose T, Imai Y . Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide. Hypertens Res 2015; 38: 701\u2013707.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahlof","year":"2005","unstructured":"Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895\u2013906.","journal-title":"Lancet"},{"key":"BFhr201756_CR9","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ Investigators AT. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417\u20132428.","journal-title":"N Engl J Med"},{"key":"BFhr201756_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253\u2013390.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/hr.2012.125","volume":"35","author":"K Asayama","year":"2012","unstructured":"Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y . Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res 2012; 35: 1102\u20131110.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.114.04262","volume":"64","author":"K Kario","year":"2014","unstructured":"Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K . Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989\u2013996.","journal-title":"Hypertension"},{"key":"BFhr201756_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MBP.0000000000000121","volume":"20","author":"MH Jung","year":"2015","unstructured":"Jung MH, Kim GH, Kim JH, Moon KW, Yoo KD, Rho TH, Kim CM . Reliability of home blood pressure monitoring: in the context of validation and accuracy. Blood Press Monit 2015; 20: 215\u2013220.","journal-title":"Blood Press Monit"},{"key":"BFhr201756_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3109\/10641963.2013.764890","volume":"35","author":"C Tsakiri","year":"2013","unstructured":"Tsakiri C, Stergiou GS, Boivin JM . Implementation of home blood pressure monitoring in clinical practice. Clin Exp Hypertens 2013; 35: 558\u2013562.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr201756_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(10)60964-6","volume":"376","author":"RJ McManus","year":"2010","unstructured":"McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, Kaambwa B, Banting M, Bryan S, Little P, Williams B, Hobbs FD . Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 2010; 376: 163\u2013172.","journal-title":"Lancet"},{"key":"BFhr201756_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895\u2013905.","journal-title":"Lancet"},{"key":"BFhr201756_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.1997.03540350075038","volume":"277","author":"World Medical Association declaration of Helsinki","year":"1997","unstructured":"World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925\u2013926.","journal-title":"JAMA"},{"key":"BFhr201756_CR18","first-page":"3","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3\u2013107.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MBP.0000000000000127","volume":"20","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Yoshika M, Yokoi T . Validation of two automatic devices: Omron HEM-7252G-HP and Omron HEM-7251G for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit 2015; 20: 286\u2013290.","journal-title":"Blood Press Monit"},{"key":"BFhr201756_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982\u2013992.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201756_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB . The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441\u20131446.","journal-title":"N Engl J Med"},{"key":"BFhr201756_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/HYPERTENSIONAHA.111.00138","volume":"61","author":"K Asayama","year":"2013","unstructured":"Asayama K, Kikuya M, Schutte R, Thijs L, Hosaka M, Satoh M, Hara A, Obara T, Inoue R, Metoki H, Hirose T, Ohkubo T, Staessen JA, Imai Y . Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension 2013; 61: 61\u201369.","journal-title":"Hypertension"},{"key":"BFhr201756_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.112.202143","volume":"60","author":"R Schutte","year":"2012","unstructured":"Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, Gu YM, Kuznetsova T, Jacobs L, Staessen JA . Within-subject blood pressure level\u2014not variability\u2014predicts fatal and nonfatal outcomes in a general population. Hypertension 2012; 60: 1138\u20131147.","journal-title":"Hypertension"},{"key":"BFhr201756_CR24","doi-asserted-by":"publisher","first-page":"e002995","DOI":"10.1161\/JAHA.115.002995","volume":"5","author":"K Asayama","year":"2016","unstructured":"Asayama K, Ohkubo T, Hanazawa T, Watabe D, Hosaka M, Satoh M, Yasui D, Staessen JA, Imai Y, Hypertensive Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure Study Investigators. Does antihypertensive drug class affect day-to-day variability of self-measured home blood pressure? The HOMED-BP Study. J Am Heart Assoc 2016; 5: e002995.","journal-title":"J Am Heart Assoc"},{"key":"BFhr201756_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/01.hjh.0000160205.81652.5a","volume":"23","author":"L Mena","year":"2005","unstructured":"Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T . A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23: 505\u2013511.","journal-title":"J Hypertens"},{"key":"BFhr201756_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/HYPERTENSIONAHA.109.140798","volume":"55","author":"TW Hansen","year":"2010","unstructured":"Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bj\u00f6rklund-Bodeg\u00e5rd K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA . Prognostic value of reading-to-reading blood pressure variability over 24\u2009hours in 8938 subjects from 11 populations. Hypertension 2010; 55: 1049\u20131057.","journal-title":"Hypertension"},{"key":"BFhr201756_CR27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/HJH.0000000000000902","volume":"34","author":"M Satoh","year":"2016","unstructured":"Satoh M, Haga T, Hosaka M, Obara T, Metoki H, Murakami T, Kikuya M, Inoue R, Asayama K, Mano N, Ohkubo T, Imai Y . The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements. J Hypertens 2016; 34: 1218\u20131223.","journal-title":"J Hypertens"},{"key":"BFhr201756_CR28","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/HJH.0b013e328353f1fe","volume":"30","author":"H Metoki","year":"2012","unstructured":"Metoki H, Ohkubo T, Kikuya M, Asayama K, Inoue R, Obara T, Hirose T, Sato M, Imai Y . The velocity of antihypertensive effect of losartan\/hydrochlorothiazide and angiotensin II receptor blocker. J Hypertens 2012; 30: 1478\u20131486.","journal-title":"J Hypertens"},{"key":"BFhr201756_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMsa1406751","volume":"372","author":"AE Moran","year":"2015","unstructured":"Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, Williams L, Bibbins-Domingo K, Coxson PG, Goldman L . Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med 2015; 372: 447\u2013455.","journal-title":"N Engl J Med"},{"key":"BFhr201756_CR30","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr., Pajewski NM Sprint Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >\/=75 years: a randomized clinical trial. JAMA 2016; 315: 2673\u20132682.","journal-title":"JAMA"},{"key":"BFhr201756_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387: 957\u2013967.","journal-title":"Lancet"},{"key":"BFhr201756_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.111.178657","volume":"59","author":"JK Johansson","year":"2012","unstructured":"Johansson JK, Niiranen TJ, Puukka PJ, Jula AM . Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension 2012; 59: 212\u2013218.","journal-title":"Hypertension"},{"key":"BFhr201756_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/HYPERTENSIONAHA.115.04800","volume":"65","author":"K Kario","year":"2015","unstructured":"Kario K . Prognosis in relation to blood pressure variability: pro side of the argument. Hypertension 2015; 65: 1163\u20131169.","journal-title":"Hypertension"},{"key":"BFhr201756_CR34","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.115.04808","volume":"65","author":"K Asayama","year":"2015","unstructured":"Asayama K, Wei FF, Hara A, Hansen TW, Li Y, Staessen JA . Prognosis in relation to blood pressure variability: con side of the argument. Hypertension 2015; 65: 1170\u20131179.","journal-title":"Hypertension"},{"key":"BFhr201756_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/hr.2015.104","volume":"39","author":"S Umemoto","year":"2016","unstructured":"Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T Combination Therapy of Hypertension to Prevent Cardiovascular Events CTG. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial. Hypertens Res 2016; 39: 46\u201353.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/hr.2014.153","volume":"38","author":"K Asayama","year":"2015","unstructured":"Asayama K, Wei FF, Liu YP, Hara A, Gu YM, Schutte R, Li Y, Thijs L, Staessen JA . Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure. Hypertens Res 2015; 38: 97\u2013101.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/jhh.2008.161","volume":"23","author":"T Fujiwara","year":"2009","unstructured":"Fujiwara T, Ii Y, Hatsuzawa J, Murase H, Watanabe T, Murakami M, Kimura N, Buch J, Tsuchihashi T, Saruta T . The phase III, double-blind, parallel-group controlled study of amlodipine 10\u2009mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5\u2009mg once daily. J Hum Hypertens 2009; 23: 521\u2013529.","journal-title":"J Hum Hypertens"},{"key":"BFhr201756_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/hr.2015.3","volume":"38","author":"H Rakugi","year":"2015","unstructured":"Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Shirakawa M, Azuma K, Fujita KP . Add-on effect of hydrochlorothiazide 12.5\u2009mg in Japanese subjects with essential hypertension uncontrolled with losartan 50\u2009mg and amlodipine 5\u2009mg. Hypertens Res 2015; 38: 329\u2013335.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","volume":"65","author":"GC Roush","year":"2015","unstructured":"Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA . Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension 2015; 65: 1041\u20131046.","journal-title":"Hypertension"},{"key":"BFhr201756_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/ajh\/hpv050","volume":"28","author":"P Chen","year":"2015","unstructured":"Chen P, Chaugai S, Zhao F, Wang DW . Cardioprotective effect of thiazide-like diuretics: a meta-analysis. Am J Hypertens 2015; 28: 1453\u20131463.","journal-title":"Am J Hypertens"},{"key":"BFhr201756_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/hr.2016.100","volume":"40","author":"J Higaki","year":"2017","unstructured":"Higaki J, Komuro I, Shiki K, Ugai H, Taniguchi A, Ikeda H, Kuroki D, Nishimura S, Ogihara T . The efficacy and long-term safety of a triple combination of 80\u2009mg telmisartan, 5\u2009mg amlodipine and 12.5\u2009mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension. Hypertens Res 2017; 40: 51\u201360.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR . Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55: 399\u2013407.","journal-title":"Hypertension"},{"key":"BFhr201756_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1291\/hypres.27.141","volume":"27","author":"M Inaba","year":"2004","unstructured":"Inaba M, Noguchi Y, Yamamoto T, Imai T, Hatano M, Yagi S, Katayama S . Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens Res 2004; 27: 141\u2013145.","journal-title":"Hypertens Res"},{"key":"BFhr201756_CR44","unstructured":"Ministry of Health, Labour and Welfare. National Health Insurance Drug List. 2017; 2017."},{"key":"BFhr201756_CR45","doi-asserted-by":"publisher","first-page":"205031211456331","DOI":"10.1177\/2050312114563318","volume":"2","author":"H Teramachi","year":"2014","unstructured":"Teramachi H, Takahashi T, Tachi T, Noguchi Y, Nagasawa H, Ino Y, Mizui T, Goto C, Tsuchiya T . Influence of angiotensin II receptor blocker combination tablet prescription on drug number and cost. SAGE Open Med 2014; 2: 2050312114563318.","journal-title":"SAGE Open Med"},{"key":"BFhr201756_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1472-6963-13-124","volume":"13","author":"M Akazawa","year":"2013","unstructured":"Akazawa M, Fukuoka K . Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis. BMC Health Serv Res 2013; 13: 124.","journal-title":"BMC Health Serv Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/hr201756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr201756","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/hr.2017.56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/hr201756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:27:18Z","timestamp":1641004038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10,5]]}},"alternative-id":["BFhr201756"],"URL":"https:\/\/doi.org\/10.1038\/hr.2017.56","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"assertion":[{"value":"4 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ST received grant funds from Sumitomo Dainippon Pharma and OmronHealthcare, Kyoto, Japan. TK received grant funds and lecture fees from Sumitomo Dainippon Pharma. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}